RNSG 1301 EXAM 1 QUESTIONS WITH CORRECT
ANSWERS
Generic |drugs |- |CORRECT |ANSWER✔✔-drugs |sold |by |their |generic |name; |not |brand |(or |trade) |
name |products
Brand |name |- |CORRECT |ANSWER✔✔-name |given |to |a |drug |by |the |pharmaceutical |company |
that |developed |it; |also |called |a |trade |name
Genetic |drugs |vs |Brand |name |- |CORRECT |ANSWER✔✔-Once |the |patent |on |a |brand |name |runs
|out |manufactures |develop |genetic |drugs |which |are |intended |work |on |in |the |same |way |
(quality, |dosage, |strength, |and |route |of |administration). |
The |bioavailability |of |the |generic |drugs |may |differ |from |the |brand |name. |This |is |why |providers
|might |specify |"dispense |as |written" |so |brand |name |product |may |use |especially |in |drugs |that |
have |narrow |safety |margins.
Control |substance |- |(C-I) |Schedule |I |- |CORRECT |ANSWER✔✔-High |abuse |potential |and |no |
accepted |medical |use |(heroin, |marijuana, |LSD)
Control |substance |- |(C-II) |Schedule |II |- |CORRECT |ANSWER✔✔-High |abuse |potential |with |
severe |dependence |liability |(narcotics, |amphetamines, |and |barbiturates)
Example: |Cocaine, |methamphetamines, |methadone, |Dilaudid, |Demerol, |Oxycodone, |Fentanyl, |
Morphine, |Adderall, |Ritalin, |Dexedrine. |
Written |prescription |only, |no |refills
, Control |substance |- |(C-III) |Schedule |III |- |CORRECT |ANSWER✔✔-Less |abuse |potential |than |
schedule |II |drugs |and |moderate |dependence |liability |(nonbarbiturate |sedatives, |
nonamphetamine |stimulants, |limited |amounts |of |certain |narcotics) |
< |15 |mg |hydrocodone |per |dosage |unit |(Vicodin) |; |< |90 |mg |of |codeine |p3er |dosage |unit |
(Tylenol |w/ |codeine); |ketamine; |anabolic |steroids; |testosterone |
Written/Oral |Rx |that |expired |w/n |6mos. |No |more |than |5 |refills.
Control |substance |- |(C-IV) |Schedule |IV |- |CORRECT |ANSWER✔✔-Less |abuse |potential |than |
schedule |III |and |limited |dependence |liability |(some |sedatives, |antianxiety |agents, |and |
nonnarcotic |analgesics)
Examples: |Xanax, |Soma, |Valium, |Ativan, |Talwin, |Ambien |
Written/Oral |Rx |that |expires |w/n |6 |mons. |No |more |than |5 |refills.
Control |substance |- |(C-V) |Schedule |V |- |CORRECT |ANSWER✔✔-Limited |abuse |potential |
Cough |suppressants |< |200 |mg |codeine/100 |mL |(Robitussin |AC), |Lomotil, |Motofen, |Lyrica, |
Parepectolin |
Written |Rx |or |OTC; |must |be |18 |yo, |ID |must |be |showed, |and |dispensing |must |be |recorded
The |Controlled |Substances |Act |of |1970 |- |CORRECT |ANSWER✔✔-Control |over |the |coding |of |
drugs |and |the |enforcement |of |these |codes |to |the |FDA |and |the |Drug |Enforcement |Agency |
(DEA), |a |part |of |the |U.S. |Department |of |Justice.
ANSWERS
Generic |drugs |- |CORRECT |ANSWER✔✔-drugs |sold |by |their |generic |name; |not |brand |(or |trade) |
name |products
Brand |name |- |CORRECT |ANSWER✔✔-name |given |to |a |drug |by |the |pharmaceutical |company |
that |developed |it; |also |called |a |trade |name
Genetic |drugs |vs |Brand |name |- |CORRECT |ANSWER✔✔-Once |the |patent |on |a |brand |name |runs
|out |manufactures |develop |genetic |drugs |which |are |intended |work |on |in |the |same |way |
(quality, |dosage, |strength, |and |route |of |administration). |
The |bioavailability |of |the |generic |drugs |may |differ |from |the |brand |name. |This |is |why |providers
|might |specify |"dispense |as |written" |so |brand |name |product |may |use |especially |in |drugs |that |
have |narrow |safety |margins.
Control |substance |- |(C-I) |Schedule |I |- |CORRECT |ANSWER✔✔-High |abuse |potential |and |no |
accepted |medical |use |(heroin, |marijuana, |LSD)
Control |substance |- |(C-II) |Schedule |II |- |CORRECT |ANSWER✔✔-High |abuse |potential |with |
severe |dependence |liability |(narcotics, |amphetamines, |and |barbiturates)
Example: |Cocaine, |methamphetamines, |methadone, |Dilaudid, |Demerol, |Oxycodone, |Fentanyl, |
Morphine, |Adderall, |Ritalin, |Dexedrine. |
Written |prescription |only, |no |refills
, Control |substance |- |(C-III) |Schedule |III |- |CORRECT |ANSWER✔✔-Less |abuse |potential |than |
schedule |II |drugs |and |moderate |dependence |liability |(nonbarbiturate |sedatives, |
nonamphetamine |stimulants, |limited |amounts |of |certain |narcotics) |
< |15 |mg |hydrocodone |per |dosage |unit |(Vicodin) |; |< |90 |mg |of |codeine |p3er |dosage |unit |
(Tylenol |w/ |codeine); |ketamine; |anabolic |steroids; |testosterone |
Written/Oral |Rx |that |expired |w/n |6mos. |No |more |than |5 |refills.
Control |substance |- |(C-IV) |Schedule |IV |- |CORRECT |ANSWER✔✔-Less |abuse |potential |than |
schedule |III |and |limited |dependence |liability |(some |sedatives, |antianxiety |agents, |and |
nonnarcotic |analgesics)
Examples: |Xanax, |Soma, |Valium, |Ativan, |Talwin, |Ambien |
Written/Oral |Rx |that |expires |w/n |6 |mons. |No |more |than |5 |refills.
Control |substance |- |(C-V) |Schedule |V |- |CORRECT |ANSWER✔✔-Limited |abuse |potential |
Cough |suppressants |< |200 |mg |codeine/100 |mL |(Robitussin |AC), |Lomotil, |Motofen, |Lyrica, |
Parepectolin |
Written |Rx |or |OTC; |must |be |18 |yo, |ID |must |be |showed, |and |dispensing |must |be |recorded
The |Controlled |Substances |Act |of |1970 |- |CORRECT |ANSWER✔✔-Control |over |the |coding |of |
drugs |and |the |enforcement |of |these |codes |to |the |FDA |and |the |Drug |Enforcement |Agency |
(DEA), |a |part |of |the |U.S. |Department |of |Justice.
